Immunoscintigraphy of local recurrent rectal cancer with 99mTc-labeled anti-CEA monoclonal antibody CL58

World Journal of Gastroenterology

Volumn 13, Issue 12, 2007, Pages 1841-1846

  Yao, Yun Feng ^a   Yang, Zhi ^a   Li, Zhen Fu ^a   Gu, Jin ^a  

^a PEKING UNIVERSITY CANCER HOSPITAL AND INSTITUTE   (China)

Author keywords

Immunoscintigraphy; Monoclonal antibody; Rectal cancer; Recurrence

Indexed keywords

ANTINEOPLASTIC AGENT; CARCINOEMBRYONIC ANTIGEN; CARCINOEMBRYONIC ANTIGEN MONOCLONAL ANTIBODY CL58 TC 99M; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG;

ABDOMINAL DISEASE; ABDOMINAL SURGERY; ADJUVANT THERAPY; ADULT; ARTICLE; BONE METASTASIS; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DRUG ACCUMULATION; EARLY DIAGNOSIS; ECHOGRAPHY; FEMALE; FOLLOW UP; GASTROINTESTINAL ENDOSCOPY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOSCINTIGRAPHY; INTERMETHOD COMPARISON; LIVER METASTASIS; LUNG METASTASIS; LYMPH NODE METASTASIS; MALE; POSTOPERATIVE CARE; PROTEIN BLOOD LEVEL; RECTUM CANCER; RECURRENT CANCER; SENSITIVITY AND SPECIFICITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STOMACH DISEASE; SURVIVAL TIME;

EID: 34248226325     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v13.i12.1841     Document Type: Article

References (17)

1. Bakx R, van Tinteren H, van Lanschot JJ, Zoetmulder FA. Surgical treatment of locally recurrent rectal cancer. Eur J Surg Oncol 2004; 30: 857-863
2. Yasuda S, Makuuchi Y, Sadahiro S, Mukai M, Tokunaga N, Tajima T, Shohtsu A. Colorectal cancer recurrence in the liver: detection by PET. Tokai J Exp Clin Med 1998; 23: 167-171
3. Schlag P, Lehner B, Strauss LG, Georgi P, Herfarth C. Scar or recurrent rectal cancer. Positron emission tomography is more helpful for diagnosis than immunoscintigraphy. Arch Surg 1989; 124: 197-200
4. 99mTc scintigraphy. Hepatogastroenterology 2000; 47: 405-413
5. Waldmann TA. Monoclonal antibodies in diagnosis and therapy. Science 1991; 252: 1657-1662
6. Gu J, Zhao J, Li Z, Yang Z, Zhang J, Gao Z, Wang Y, Xu G. Clinical application of radioimmunoguided surgery in colorectal cancer using 1251-labeled carcinoembryonic antigen-specific monoclonal antibody submucosally. Dis Colon Rectum 2003; 46: 1659-1666
7. Heald RJ, Moran BJ, Ryall RD, Sexton R, MacFarlane JK. Rectal cancer: the Basingstoke experience of total mesorectal excision, 1978-1997. Arch Surg 1998; 133: 894-899
8. Enker WE, Thaler FIT, Cranor ML, Polyak T. Total mesorectal excision in the operative treatment of carcinoma of the rectum. J Am Coll Surg 1995; 181: 335-346
9. de Anda EH, Lee SH, Finne CO, Rothenberger DA, Madoff RD, Garcia-Aguilar J. Endorectal ultrasound in the follow-up of rectal cancer patients treated by local excision or radical surgery. Dis Colon Rectum 2004; 47: 818-824
10. Blomqvist L, Holm T, Goranson H, Jacobsson H, Ohlsen H, Larsson SA. MR imaging, CT and CEA scintigraphy in the diagnosis of local recurrence of rectal carcinoma. Acta Radiol 1996; 37: 779-784
11. Blomqvist L, OhIsen H, Hindmarsh T, Jonsson E, Holm T. Local recurrence of rectal cancer: MR imaging before and after oral superparamagnetic particles vs contrast-enhanced computed tomography. Eur Radiol 2000; 10: 1383-1389
12. Wolf RF, Cohen AM. The miniscule benefit of serial carcinoembryonic antigen monitoring after effective curative treatment for primary colorectal cancer. J Am Coll Surg 1997; 185: 60-64
13. Chiappa A, Biffi R, Zbar AP, Luca F, Crotti C, Bertani E, Biella F, Zampino G, Orecchia R, Fazio N, Venturino M, Crosta C, Pruneri GC, Grassi C, Andreoni B. Results of treatment of distal rectal carcinoma since the introduction of total mesorectal excision: a single unit experience, 1994-2003. Int J Colorectal Dis 2005; 20: 221-230
14. Guyot F, Faivre J, Manfredi S, Meny B, Bonithon-Kopp C, Bouvier AM. Time trends in the treatment and survival of recurrences from colorectal cancer. Ann Oncol 2005; 16: 756-761
15. Baulieu F, Bourlier P, Scotto B, Mor C, Eder V, Picon L, De Calan L, Dorval E, Pottier JM, Baulieu JL. The value of immunoscintigraphy in the detection of recurrent colorectal cancer. Nucl Med Commun 2001; 22: 1295-1304
16. Lucha PA Jr, Rosen L, Olenwine JA, Reed JF 3rd, Riether RD, Stasik JJ Jr, Khubchandani IT. Value of carcinoembryonic antigen monitoring in curative surgery for recurrent colorectal carcinoma. Dis Colon Rectum 1997; 40: 145-149
17. Suwanagool P, Fujimori T, Maeda S. Value of tissue carcinoembryonic antigen in patients with colorectal carcinoma. Asian Pac J Allergy Immunol 1990; 8: 33-37